EPA vs DHA: Which Omega-3 Do You Actually Need?

Understanding Omega-3 Fatty Acids: EPA and DHA Are Not the Same

Omega-3 supplementation is often discussed as though fish oil were a single homogeneous product. In reality, the two major omega-3 fatty acids in marine sources — eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — are chemically distinct compounds with different tissue distributions, different metabolic fates, and different clinical applications. Choosing the right emphasis matters.

What EPA Does

EPA (eicosapentaenoic acid) is a 20-carbon omega-3 fatty acid. Its primary role in human physiology is as a precursor for eicosanoids — a family of signalling molecules that includes prostaglandins, thromboxanes, and leukotrienes derived from the omega-3 pathway. These EPA-derived eicosanoids are generally anti-inflammatory in character, counteracting the pro-inflammatory eicosanoids produced from arachidonic acid (an omega-6 fatty acid abundant in the Western diet).

EPA is the omega-3 most directly relevant to inflammatory modulation. It is also the fatty acid with the strongest evidence for cardiovascular outcomes: the REDUCE-IT trial (2018) demonstrated that high-dose purified EPA (icosapentaenoic acid ethyl ester, 4g daily) significantly reduced cardiovascular events in a high-risk population on statins. The effect size was substantial enough to prompt regulatory approval of the drug in both the US and Europe.

EPA is also the omega-3 most strongly associated with mood and mental health. A 2019 meta-analysis found that supplements with a higher EPA-to-DHA ratio were more effective for depression than DHA-dominant formulations. The hypothesis is that EPA's anti-inflammatory effects reduce neuroinflammation, which is increasingly implicated in the pathophysiology of depression.

What DHA Does

DHA (docosahexaenoic acid) is a 22-carbon omega-3 that serves a structural rather than primarily signalling role. It is a major component of neuronal cell membranes, constituting approximately 40% of the polyunsaturated fatty acids in the brain. It is also the dominant fatty acid in the photoreceptor membranes of the retina. Its presence in these membranes affects membrane fluidity and the function of embedded proteins, including neurotransmitter receptors and ion channels.

During gestation and early infancy, DHA is critical for brain and retinal development. Maternal DHA status is strongly associated with foetal neurodevelopment, and the NHS advises that pregnant women include oily fish in their diet or supplement with DHA.

In adults, DHA deficiency is associated with cognitive decline and has been studied in the context of dementia and Alzheimer's disease, though results from intervention trials have been mixed, likely because supplementation may need to begin before structural changes are established.

Choosing Based on Goal

If the primary goal is mood support or reducing systemic inflammation (e.g., joint discomfort, skin conditions, general inflammatory load), an EPA-dominant formulation — ideally with an EPA:DHA ratio of at least 2:1 — is the evidence-based choice.

If the goal is cognitive maintenance, brain health in ageing, or support during pregnancy and infancy, a formulation with substantial DHA is more appropriate.

For general cardiovascular health in adults, both EPA and DHA appear beneficial. The European Society of Cardiology and NHS guidelines focus on total long-chain omega-3 intake rather than the specific ratio for primary prevention.

Algae-Based Omega-3 for Vegans

Fish do not synthesise EPA and DHA; they accumulate them by consuming microalgae. Supplementing with algae oil is therefore nutritionally equivalent to fish oil for these two fatty acids, and eliminates concerns about heavy metal contamination that can affect some fish oil products. The sustainability profile is also considerably better. Several well-designed trials have now confirmed comparable bioavailability of EPA and DHA from algae versus fish sources.

ALA (alpha-linolenic acid), the plant-based omega-3 found in flaxseed, chia, and hemp, is a poor substitute. Conversion of ALA to EPA in the human body is approximately 5–8%, and conversion to DHA is less than 1%. Plant-sourced ALA cannot reliably meet the body's EPA and DHA requirements.

Dosing and Quality

A combined intake of at least 2 g of EPA+DHA per day is commonly cited as the threshold at which meaningful physiological effects are observed. Cardiovascular trials typically use 1–4 g daily. Quality matters considerably: omega-3 oils are highly susceptible to oxidation. Fish oil that smells strongly rancid provides reduced benefit and may cause harm through lipid peroxidation products. Look for products certified by the International Fish Oil Standards (IFOS) programme or equivalent, and check the oxidation (TOTOX) values. Storing fish oil in a cool, dark environment and consuming within the stated use-by date is important.